Home ETF List About

Portfolio Holdings Detail for ISIN IE00B5BMR087
Stock Name / FundiShares Core S&P 500 UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCSP1(GBX) LSE
ETF TickerSXR8(EUR) F
ETF TickerCSP1.LS(GBX) CXE
ETF TickerCSPX.AS(EUR) CXE
ETF TickerCSPX.LS(USD) CXE
ETF TickerCSSPX.MI(EUR) CXE
ETF TickerCSSPXz(USD) CXE
ETF TickerSXR8.DE(EUR) CXE
ETF TickerCSSPX(EUR) ETF Plus
ETF TickerCSPX(EUR) Euronext Amsterdam
ETF TickerCSP1.L(GBP) LSE

Holdings detail for VRTX

Stock NameVertex Pharmaceuticals Inc
TickerVRTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92532F1003
LEI54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY
(RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
Why This Biotech Company Could Be a Growth Stock Powerhouse
Key PointsThis biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. - 2025-09-17 06:10:00
3 Absurdly Cheap Stocks to Buy for the Long Haul
Key PointsThese stocks are all down for the year, and things could get worse before they get better. - 2025-09-12 08:30:00
My 2 Favorite Stocks to Buy Right Now
Key PointsAmazon has multiple moats and paths to grow. - 2025-08-31 05:51:00
Capital Group Growth ETF Experiences Big Inflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $162.3 million dollar inflow -- that's a 1.1% increase week over week i - 2025-08-29 11:52:16
Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
2 Growth Stocks That Are No-Brainer Buys Right Now
Key PointsVertex Pharmaceuticals' recent dip presents an excellent buying opportunity, given its promising prospects. - 2025-08-15 09:30:00
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
The Smartest Growth Stocks to Buy With $1,000 Right Now
Key PointsVertex Pharmaceuticals' recent sell-off was overdone. - 2025-08-09 05:46:00
5 Top Stocks to Buy in August
Key PointsThe pullback in Netflix, Costco, and ASML is a buying opportunity. - 2025-08-08 07:45:00
Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 14:19:48
Wednesday's ETF with Unusual Volume: LSGR
The Natixis Loomis Sayles Focused Growth ETF is seeing unusually high volume in afternoon trading Wednesday, with over 805,000 shares traded versus three month average volume of about 45,000. Shares of LSGR were up about 0.4% on the day. Components of that ETF with the highest - 2025-08-06 13:11:25
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:43:55
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:20:27
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:31:46
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:01:41
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:50:42
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:02:58
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 05:54:32
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 04:21:54
Stocks Settle Lower as US Service Sector Activity Weakens
The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 02:12:19
Stocks Pressured by Disappointing US Service Sector News
The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.62%. September E-mini S&P futures (ESU25 ) are down -0.55%, and September E-mini Nasdaq futures... - 2025-08-05 19:47:15

iShares Core S&P 500 UCITS ETF USD (Acc) VRTX holdings

DateNumber of VRTX Shares HeldBase Market Value of VRTX SharesLocal Market Value of VRTX SharesChange in VRTX Shares HeldChange in VRTX Base ValueCurrent Price per VRTX Share HeldPrevious Price per VRTX Share Held
2025-10-01 (Wednesday)606,819USD 245,282,308USD 245,282,308
2025-09-30 (Tuesday)606,574USD 237,558,641USD 237,558,641
2025-09-29 (Monday)606,224VRTX holding increased by 315USD 239,646,409VRTX holding increased by 5926101USD 239,646,409315USD 5,926,101 USD 395.31 USD 385.735
2025-09-26 (Friday)605,909VRTX holding increased by 385USD 233,720,308VRTX holding increased by 2488858USD 233,720,308385USD 2,488,858 USD 385.735 USD 381.87
2025-09-25 (Thursday)605,524VRTX holding increased by 490USD 231,231,450VRTX holding increased by 3363545USD 231,231,450490USD 3,363,545 USD 381.87 USD 376.62
2025-09-24 (Wednesday)605,034VRTX holding decreased by -2374USD 227,867,905VRTX holding decreased by -7265806USD 227,867,905-2,374USD -7,265,806 USD 376.62 USD 387.11
2025-09-18 (Thursday)607,408VRTX holding increased by 36USD 235,133,711VRTX holding decreased by -10359USD 235,133,71136USD -10,359 USD 387.11 USD 387.15
2025-09-17 (Wednesday)607,372VRTX holding increased by 324USD 235,144,070VRTX holding decreased by -2430235USD 235,144,070324USD -2,430,235 USD 387.15 USD 391.36
2025-09-16 (Tuesday)607,048VRTX holding increased by 144USD 237,574,305VRTX holding decreased by -1066417USD 237,574,305144USD -1,066,417 USD 391.36 USD 393.21
2025-09-15 (Monday)606,904USD 238,640,722USD 238,640,722
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00B5BMR087

Show aggregate share trades of VRTX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-29BUY315 395.310* 462.12
2025-09-26BUY385 385.735* 462.54
2025-09-25BUY490 381.870* 462.98
2025-09-24SELL-2,374 376.620* 463.46 Profit of 1,100,255 on sale
2025-09-18BUY36 387.110* 463.89
2025-09-17BUY324 387.150* 464.32
2025-09-16BUY144 391.360* 464.73
2025-09-11BUY180 397.370* 465.11
2025-09-09BUY180 396.480* 465.95
2025-09-08BUY72 395.250* 466.36
2025-09-05BUY828 396.120* 466.76
2025-08-22BUY36 395.120* 467.18
2025-08-21BUY108 397.460* 467.59
2025-08-20BUY144 394.360* 468.03
2025-08-19BUY216 390.760* 468.49
2025-08-01BUY648 462.130* 468.52
2025-07-31BUY36 456.870* 468.60
2025-07-30BUY288 469.160* 468.59
2025-07-29BUY36 468.410* 468.59
2025-07-24BUY36 472.270* 468.57
2025-07-23BUY216 476.950* 468.52
2025-07-22BUY324 470.130* 468.51
2025-07-21BUY72 458.490* 468.57
2025-07-18SELL-360 459.810* 468.63 Profit of 168,705 on sale
2025-07-17BUY36 463.270* 468.66
2025-07-16BUY144 469.550* 468.65
2025-07-15SELL-540 464.200* 468.68 Profit of 253,089 on sale
2025-07-11SELL-72 468.850* 468.68 Profit of 33,745 on sale
2025-07-10BUY288 479.530* 468.61
2025-07-09BUY288 478.965* 468.54
2025-07-08BUY216 466.360* 468.56
2025-07-07SELL-828 459.410* 468.62 Profit of 388,016 on sale
2025-07-02SELL-1,044 457.030* 468.82 Profit of 489,447 on sale
2025-06-30BUY612 445.200* 468.98
2025-06-27BUY324 441.300* 469.17
2025-06-25SELL-72 445.820* 469.51 Profit of 33,805 on sale
2025-06-24BUY36 450.270* 469.64
2025-06-23BUY936 443.540* 469.83
2025-06-20BUY2,600 440.870* 470.03
2025-06-18SELL-210 448.400* 470.35 Profit of 98,772 on sale
2025-06-13SELL-105 455.450* 470.81 Profit of 49,435 on sale
2025-06-12BUY105 460.060* 470.89
2025-06-11BUY140 452.440* 471.02
2025-06-06SELL-175 450.500* 471.52 Profit of 82,516 on sale
2025-06-05SELL-105 443.820* 471.73 Profit of 49,532 on sale
2025-06-04SELL-140 445.850* 471.93 Profit of 66,071 on sale
2025-06-02BUY455 445.430* 472.34
2025-05-30SELL-102 442.050* 472.58 Profit of 48,203 on sale
2025-05-29BUY35 447.090* 472.79
2025-05-28SELL-35 445.100* 473.01 Profit of 16,555 on sale
2025-05-27BUY385 446.000* 473.23
2025-05-23SELL-700 436.000* 473.84 Profit of 331,691 on sale
2025-05-22SELL-770 434.030* 474.18 Profit of 365,115 on sale
2025-05-21BUY35 435.320* 474.50
2025-05-20BUY280 447.180* 474.73
2025-05-19BUY1,015 440.660* 475.03
2025-05-16BUY945 438.650* 475.34
2025-05-15BUY770 434.380* 475.69
2025-05-14BUY700 421.160* 476.17
2025-05-13SELL-140 432.000* 476.56 Profit of 66,719 on sale
2025-05-12BUY35 439.370* 476.90
2025-05-09BUY105 424.990* 477.36
2025-05-08SELL-1,015 429.600* 477.80 Profit of 484,965 on sale
2025-05-07SELL-490 434.820* 478.19 Profit of 234,314 on sale
2025-05-06BUY1,225 450.030* 478.45
2025-05-02BUY105 501.150* 478.03
2025-05-01SELL-175 498.860* 477.84 Profit of 83,621 on sale
2025-04-30BUY105 509.500* 477.53
2025-04-29BUY245 503.500* 477.28
2025-04-28BUY523 496.490* 477.09
2025-04-25BUY490 493.840* 476.92
2025-04-24BUY140 492.470* 476.77
2025-04-23BUY385 492.420* 476.61
2025-04-22SELL-212 490.470* 476.47 Profit of 101,012 on sale
2025-04-17BUY70 489.100* 476.19
2025-04-16BUY140 485.890* 476.09
2025-04-15BUY700 500.490* 475.83
2025-04-11BUY875 484.220* 475.52
2025-04-10BUY1,435 475.490* 475.52
2025-04-09BUY280 482.300* 475.44
2025-04-08BUY735 472.370* 475.47
2025-04-07BUY839 474.560* 475.48
2025-04-04SELL-2,100 474.620* 475.50 Profit of 998,540 on sale
2025-04-02BUY245 483.490* 475.40
2025-03-31SELL-945 484.820* 475.17 Profit of 449,040 on sale
2025-03-28SELL-595 492.690* 474.96 Profit of 282,602 on sale
2025-03-27SELL-175 502.550* 474.62 Profit of 83,059 on sale
2025-03-26BUY315 500.280* 474.30
2025-03-25SELL-420 509.040* 473.86 Profit of 199,021 on sale
2025-03-24BUY245 511.740* 473.37
2025-03-21BUY420 503.200* 472.99
2025-03-19BUY66 512.520* 471.96
2025-03-18SELL-630 512.230* 471.42 Profit of 296,995 on sale
2025-03-17BUY665 513.760* 470.84
2025-03-14BUY595 504.770* 470.37
2025-03-13BUY1,146 502.920* 469.91
2025-03-12BUY1,440 495.420* 469.55
2025-03-11BUY576 488.340* 469.27
2025-03-07BUY342 488.290* 468.53
2025-03-06SELL-324 485.720* 468.27 Profit of 151,720 on sale
2025-03-05BUY1,122 491.640* 467.91
2025-03-04BUY216 486.220* 467.63
2025-03-03BUY972 483.310* 467.38
2025-02-28SELL-252 479.790* 467.18 Profit of 117,728 on sale
2025-02-27BUY36 474.500* 467.06
2025-02-26SELL-72 479.100* 466.86 Profit of 33,614 on sale
2025-02-25BUY684 480.350* 466.63
2025-02-21BUY504 484.240* 466.05
2025-02-20BUY288 480.330* 465.80
2025-02-19BUY72 471.760* 465.69
2025-02-18BUY180 462.110* 465.76
2025-02-13BUY612 462.580* 466.08
2025-02-12BUY216 453.200* 466.34
2025-02-11SELL-72 455.220* 466.57 Profit of 33,593 on sale
2025-02-07SELL-288 469.320* 466.44 Profit of 134,334 on sale
2025-02-06BUY144 481.160* 466.12
2025-02-04BUY1,260 482.280* 465.24
2025-02-03BUY468 470.370* 465.12
2025-01-31BUY108 461.680* 465.21
2025-01-30BUY72 438.400* 465.86
2025-01-29BUY684 441.520* 466.47
2025-01-28BUY324 440.680* 467.13
2025-01-27BUY504 443.880* 467.74
2025-01-24BUY324 439.620* 468.50
2025-01-23BUY936 439.730* 469.30
2025-01-22BUY612 428.000* 470.48
2025-01-06BUY360 402.490* 472.48
2024-12-10BUY252 469.220* 472.58
2024-12-09BUY288 473.980* 472.54
2024-12-06BUY432 462.100* 472.87
2024-12-05BUY108 459.920* 473.30
2024-12-04BUY396 463.980* 473.62
2024-12-03BUY1,269 456.970* 474.22
2024-12-02BUY106 465.730* 474.53
2024-11-29BUY828 468.130* 474.78
2024-11-27BUY972 464.560* 475.63
2024-11-26BUY2,088 467.070* 476.00
2024-11-25BUY2,160 461.710* 476.65
2024-11-22BUY2,520 450.970* 477.88
2024-11-21BUY396 450.370* 479.25
2024-11-20BUY360 451.230* 480.73
2024-11-19BUY324 448.010* 482.54
2024-11-18BUY2,916 467.010* 483.46
2024-11-12BUY1,008 490.000* 483.05
2024-11-11BUY684 501.720* 481.81
2024-11-08BUY516 516.740* 479.31
2024-11-07BUY3,204 502.450* 477.53
2024-11-06BUY972 493.640* 476.19
2024-11-05BUY1,434 499.880* 474.03
2024-11-04BUY252 472.800* 474.16
2024-11-01BUY576 471.120* 474.49
2024-10-31BUY140 475.980* 474.31
2024-10-30BUY348 475.080* 474.20
2024-10-29BUY840 470.360* 474.84
2024-10-28SELL-245 476.370* 474.53 Profit of 116,260 on sale
2024-10-25BUY420 477.700* 473.74
2024-10-24BUY280 471.910* 474.35
2024-10-23BUY350 470.050* 476.50
2024-10-22BUY905 474.910* 478.09
2024-10-21BUY980 478.090* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19253,40888822,58630.8%
2025-09-18262,27745831,58031.5%
2025-09-17158,8668901,012,59115.7%
2025-09-16233,484702769,82330.3%
2025-09-15385,60697605,41063.7%
2025-09-12198,30654325,92560.8%
2025-09-11217,651160455,82347.7%
2025-09-10441,55065640,40968.9%
2025-09-09216,563711395,37754.8%
2025-09-08285,371226594,10248.0%
2025-09-05209,9169413,66350.7%
2025-09-04236,7772,164365,71364.7%
2025-09-03212,0857457,75146.3%
2025-09-02318,587425689,37146.2%
2025-08-29136,0557344,31739.5%
2025-08-28189,040229437,53643.2%
2025-08-27204,685373919,77222.3%
2025-08-26195,209380616,64131.7%
2025-08-25205,216929405,53650.6%
2025-08-22187,538366477,72939.3%
2025-08-21357,256454694,26451.5%
2025-08-20304,195196620,59149.0%
2025-08-19193,253370598,16832.3%
2025-08-18197,043357581,90833.9%
2025-08-15213,454413509,24041.9%
2025-08-14299,335536798,76837.5%
2025-08-13342,8976,746694,04749.4%
2025-08-12361,071536689,42552.4%
2025-08-11478,7871771,141,77241.9%
2025-08-08382,6884801,467,48026.1%
2025-08-07802,7755001,747,92445.9%
2025-08-061,070,38429,9782,256,48947.4%
2025-08-052,087,74266,0274,981,30341.9%
2025-08-04329,631253766,13143.0%
2025-08-01290,545239729,07939.9%
2025-07-31227,826151513,33644.4%
2025-07-30134,793234361,14437.3%
2025-07-29124,474331372,44633.4%
2025-07-28125,989264519,86824.2%
2025-07-25136,582104432,89731.6%
2025-07-24144,869169321,73645.0%
2025-07-23182,3071,460370,78849.2%
2025-07-22193,759402450,15543.0%
2025-07-21174,38214,621318,67154.7%
2025-07-18203,35710,091296,80268.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.